Skip to main content

Distinguished Speaker Series | Dmitry V. Ivanov, PhD

-
Location
https://ucihealth.zoom.us/j/92801383742?pwd=vfI4WBKGwibdfbtyznYWvAbSg3CccO.1
Event Type

Add to Calendar: Outlook | Google | iCal

The Center for Translational Vision Research Distinguished Speaker Series, also known as "Friday Seminars" showcases innovative research across the world. The seminar series has now been expanded to include lectures by experts on topics ranging from Ophthalmology, Genetics, Biochemistry, Neurobiology, Imaging, Computational Sciences to Novel Ophthalmic Treatments.

All talks are hybrid. You can join us in person at

The Falling Leaves Foundation Building, Main Entrance Level

Conference Room (2nd Floor by signage)

847 Health Sciences Quad

You can also join us by zoom. Zoom link and information are on your right and in the calendar links above.

February 27, 2026 | Dmitry V. Ivanov, PhD

Impaired DNA Demethylation in Retinal Progenitor Cells Prevents Photoreceptor Development and Leads to Retinal Dystrophy

 

Learn More About the Distinguished Speaker Series

Featured


Dmitry V. Ivanov, PhD
Dmitry V. Ivanov, PhD
  • Dmitry V. Ivanov, PhD, Professor of Ophthalmology and Microbiology & Immunology, Evelyn F. and William L. McKnight Vision Research Center, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine

Dmitry V. Ivanov, PhD, is a Professor of Ophthalmology and of Microbiology & Immunology at the Evelyn F. and William L. McKnight Vision Research Center, within the Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine. Trained as a molecular biologist and vision scientist, Dr. Ivanov’s research focuses on the molecular and cellular mechanisms that regulate retinal development, maintenance, and disease. His work has contributed to understanding how gene regulation, stress responses, and immune-related pathways influence retinal cell survival and dysfunction. Dr. Ivanov’s laboratory investigates the interplay between retinal neurons, glial cells, and inflammatory processes in both inherited and acquired retinal disorders, with the goal of identifying molecular targets for therapeutic intervention. Using genetic, biochemical, and translational approaches, his research aims to advance strategies that preserve retinal structure and function and prevent vision loss.